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Introduction
Mayaro virus (MAYV) is an Alphavirus from the Togaviridae family, transmitted to humans mainly by the bites of Haemagogus mosquitoes (1) . MAYV was first isolated in 1954 from a febrile case in Trinidad and Tobago and maintained until the present day on restricted circulation in Central and South American forest regions on sporadic outbreaks (2) (3) (4) . However, recent studies indicate that the number of reported MAYV cases could be underestimated, warning for the risk of emergence, dispersion to new areas, and for the potential establishment of an urban epidemic cycle (1, (5) (6) (7) (8) (9) . Even in face of such risks, information regarding MAYV infection and mainly the molecular mechanism of pathogenesis is still very limited.
Due to the profile of clinical manifestations, MAYV is grouped with the arthritogenic Alphavirus such as Chikungunya (CHIKV) and Ross River (RRV).
MAYV infection promotes a febrile condition that presents a set of unspecific signs and symptoms, such as rash, headache, and ocular pain, which facilitates its misdiagnosis as other arboviroses such as dengue fever (2, (10) (11) (12) . Moreover, MAYV infected patients present a high incidence of articular and muscular pain (2, 7) , reaching about 50% and 77% of patients in some outbreaks, respectively ( 1 2 ) . In addition, it has also been reported that myalgia and articular symptoms of MAYV infections could persist for months, revealing a common feature to arthritogenic alphavirus-induced disease
.
High activation of immune response has been described in CHIKV and RRVinfected patients presenting acute and persistent symptoms (17, 18) . Analyses of muscle biopsies of CHIKV-infected patients with severe polyarthralgia and myalgia showed that symptoms persistence was associated with long-term cellular infiltrate at articular and muscle tissue (19) . However, the characteristics of the immune response induced by MAYV, the mechanisms of resolution of the infection or symptoms persistence are largely unknown. The one-year longitudinal study of Santiago et al. 2015 demonstrated that MAYV-infected patients also present prolonged immune response, with high concentrations of pro-inflammatory mediators in their serum (20) . They found lower amounts of GM-CSF, IL-5, and IL-10 in MYV-infected patients when compared to CHIKV patients, which indicates differences in the profile of the induced immune response. Consistent with this, a difference in cytokine expression between MAYV and CHIKV infection in human U937 cell lineage (21) 
Animals and infection
The experiments were performed using young WT SV129 mice (6, 11, 21 
Histology
The muscle and footpad were collected at defined days post infection and fixed with 4% of formaldehyde for 24 hours. The footpad was decalcified using EDTA solution (125g/L, pH 7.0) and then fixed. Tissues were embedded in paraffin after dehydration. Paraffin-embedded tissue sections of 5 µm were prepared and stained with hematoxylin and eosin (H&E). Images were obtained using optical microscopy with a magnification of 10 X (Olympus BX40), and images were acquired using software Leica Application Suite 3.8 (Leica).
Cytokine quantification by qPCR
Hind limb muscles were homogenized in DMEM using a fixed relation of 0. 
Statistical analyses
The statistical analyses were performed comparing means by two-tailed TStudent's tests using Graph Pad Prism version 7.00 for Windows, Graph Pad Software, La Jolla California USA, www.graphpad.com.
Results

MAYV inoculation induces clinical signs of infection in young and type-I interferon receptor deficient mice
Clinical findings suggested that MAYV induces a robust inflammatory response in patients, similar to other arthritogenic alphavirus (20) . However, MAYV tissue tropism and damage induced by infections has not been characterized yet. Hence, we first characterized whether MAYV infects or impacts animals in an age-and immunological status-dependent manner. For this, MAYV was inoculated in left hind limb footpad of young (6, 11, 21 day-old) and adult WT SV129 mice. The infection resulted in high lethality and severe weight loss for young animals (≤11-days-old) (Fig 1A and 1B) .
Interestingly, 21-day-old infected-mice had no change in body weight when compared with Mock-infected mice and were completely resistant to MAYV-induced lethality, indicating their ability to control MAYV replication. adult mice results in early lethality and severe weight loss, similarly to infection of 6-day-old WT mice (Fig 1A and 1B) . In addition, we observed intense paw edema in MAYV-injected footpad, when compared with mock (Fig 1C) , or UV-inactivated MAYV infected footpad (data not shown). Measurement of edema area showed that the swelling in IFNAR -/-was present at day 2 post infection (dpi) and maintained until 4 dpi (Fig 1D) . No alteration was observed in the counter lateral footpad. In addition to the swelling, IFNAR -/-mice presented lethargy, locomotion dysfunction, and posterior weakness. Similar diversity and intensity of clinic signals were observed in WT 11-dayold mice ( Table 1) . (Table 1) . Together, these results indicate that young mice and IFNAR -/-are highly susceptible to MAYV infection, while adult mice are resistant even in the absence of lymphocytes.
MAYV replication restriction is dependent on innate and adaptive immunity
Subsequently, we performed a temporal analysis of MAYV viremia to correlate clinical signals with the ability to control viral burden. We observed an increase in the amount of MAYV infectious particles in the blood of mice of all ages on the first day of infection (Fig 2A) . However, blood viral load was sustained at about 10 6 pfu until 4 dpi in 11-day-old WT mice, while continuously decreased in 21 day-old WT mice until undetectable levels at 5 dpi, which reinforces the age-dependence for the control of MAYV infection. In agreement with this, the infection of WT SV129 and C57BL/6 adult mice results in a brief viremia. This ability to control viral replication was completely lost in the absence of type I interferon response, as observed by the continuous increase of viremia until the lethality of IFNAR -/-mice (Fig 2A) . Despite the absence of clinical signs, MAYV infectious particle titers were sustained for a long period and maintained at about 10 4 -10 5 pfu/ml until 7 dpi in the blood of RAG1 -/-mice.
Conversely, in this same period, MAYV was no longer detected in the blood of adult WT C57BL/6. In order to identify preferential areas of replication, we evaluated the tissue distribution of MAYV at 4 dpi. MAYV infectious particles were detected in the articular and muscular tissues, as well as in liver, spleen, and brain of 11-day-old WT and adult IFNAR -/-mice (Fig 2B) . Although MAYV has a widespread distribution in mice tissues, we could observe a preferential distribution to the paw and the skeletal muscle in 11-day-old WT mice, since they presented a significantly higher viral load when compared to other peripheral tissue, as liver and spleen (Fig 2B) . A high viral load was also detected in muscular and articular tissues from the opposite side of the injection site (S1B fig). These broad distributions were not observed in the infection of the 21-day-old and 8-week-old WT animals.
MAYV establishes persistent infection in the absence of adaptive immunity
Although adult RAG1 -/-mice presented a lower viral load in all tissues when compared to young WT and adult IFNAR -/-mice 4 dpi, MAYV load was higher in RAG1 -/-mice than in WT C57BL/6 mice and viral dissemination seems to be more efficient since it was detected in the brain tissue of RAG1 -/-mice (Fig 2B) . In addition, analysis of the blood and tissues of RAG1 -/-mice demonstrated that MAYV continues to replicate actively in these animals until 40 days post infection, despite no apparent morbidity (Fig 2A and 2C) . These results indicate that adaptive immunity is determinant for the elimination of MAYV, thus contributing to avoid chronicle infection. In addition, the high viral load at 40 dpi was found in the left and right foot, and in the mice's brains (Fig 2C and S1C Fig) , suggesting the existence of preferential reservoir sites of MAYV for the maintenance of persistent infections.
MAYV induces inflammation and muscular damage in young WT and adult
IFNAR -/-mice
Since joint and muscular tissues were the main sites of MAYV replication in 11-day-old mice, we investigated whether virus replication triggers pathological alterations.
Histological analysis of H&E stained skeletal muscle of the hind limb of young WT and IFNAR -/-mice showed sites of injury, with necrosis, edema, and infiltration of inflammatory cells at 4 dpi with MAYV (Fig 3) . MAYV-induced muscular damage was similar in young WT and adult IFNAR -/-mice. However, the extension of lesions seems to be higher in young WT mice. Despite the inability to clear the viral infection, no histological alteration was found in muscles of RAG1 -/-mice even at 40 dpi (Fig 3) , correlating with the absence of clinical signals in these mice. This evidence indicates that adaptive immunity activation is determinant for viral clearance and could also be an important factor contributing to MAYV-induced inflammation and lesions. Analysis of H&E staining of the hind limb footpad at 4 dpi revealed that MAYV infection resulted in paw inflammation, with an edema area which was close to articular-associated skeletal muscle, mainly in IFNAR -/-infected mice (Fig 4) . 
MAYV infection triggers a high expression of pro-inflammatory mediator in muscular tissues
Some cytokines have been described as determinant to the progression of CHIKV induced lesions (27) . Furthermore, MAYV patients with long-term articular symptoms present high concentrations of pro-inflammatory cytokines in their serum (27) . Thus, we investigated if MAYV-induced damage was associated with the induction of a pro-inflammatory response in the muscular tissue of young WT and adult IFNAR -/-mice. The quantification of inflammatory mediator expression by qPCR showed that MAYV replication in muscular tissues triggers high expression of cytokines and chemokines, such as TNF, IL-6, KC, IL-1β, MCP-1, and RANTES ( Fig   5) . The levels of cytokine induction following MAYV infection in IFNAR -/-and young WT were very similar, except for RANTES and KC (Fig 5) . Since we found that the type-I interferon response was determinant for MAYV infection restriction, we also assessed whether MAYV was able to induce IFN-β expression in young WT mice. We found that MAYV infection promotes an increase of about 15-fold of IFN-β mRNA expression (Fig 5) . We also evaluated the expression of TGF-β and IL-10, important anti-inflammatory mediators related to a regenerative response. We found that TGF-β was down modulated in young WT mice, while being unaltered in adult IFNAR -/-mice (Fig 5) . IL-10 expression was not significantly altered in young WT mice and adult IFNAR -/-mice infected with MAYV. Some studies evaluated cytokine profiles correlating with severity and chronicity of CHIKV infection (18, 27, 30, 45) . The severity of CHIKV was associated with the levels of IL1-β, IL-6, and RANTES (27) , with IL-6 already associated with the persistence of symptoms (18) . A similar study in MAYV infected patients was conducted by Santiago et al (2015) , showing high levels of TNF, IL-6 , IL-8, IL-1Ra, IFN-γ, and others in the serum until 12 months post-acute phase (20) . Here we observed that acute MAYV infection promotes elevated expression of inflammatory mediators in the muscle tissue, revealing a translation of our model and MAYV induced disease in patients. Although the cytokine profile was similar to that seen in CHIKV infection, we cannot rule out differences in the amplitude of the inflammatory response. Interestingly, we observed that levels of TGF-β expression were reduced in young WT mice infected with MAYV. High levels of TGF-β were associated with a reduced immune response, persistent viremia, and with joint pathology in CHIKV infection in old mice (46) . Therefore, the lower levels of TGF-β in MAYV infection could be important to sustain an immune response that restricts muscle damage. Further studies assessing the role of pro-and anti-inflammatory cytokines in the generation or resolution of muscle lesions are important for exploring the possibility of employing these mediators as new therapeutic targets.
Our study presents the first description of molecular aspects of replication restriction of MAYV, together with demonstration of musculoskeletal inflammation and damage as a consequence of in vivo infection. The current knowledge about the mechanism of arthritogenic Alphavirus injury promotion was described using mainly CHIKV and RRV infection in mice models (47, 48) . However, the characterization of similarities and specificities of Alphavirus-promoted diseases is determinant for the development of effective vaccines and therapies against this group of viruses. Thus, our study also represents an important contribution as an in vivo model for further investigations on MAYV pathogenesis and also to test antiviral compounds and vaccines.
